Differential risk of 23 site-specific incident cancers and cancer-related mortality among patients with metabolic dysfunction-associated fatty liver disease: a population-based cohort study with 9.7 million Korean subjects.
Goh Eun ChungSu Jong YuJeong-Ju YooYuri ChoKyu-Na LeeDong Wook ShinYoon Jun KimJung-Hwan YoonKyungdo HanEun-Ju ChoPublished in: Cancer communications (London, England) (2023)
MAFLD classification, by applying additional etiologies other than pure metabolic origin, can be used to identify a subgroup of patients with poor cancer-related outcomes.